Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Clovis Oncology Stock Price (Quote) NASDAQ:CLVS
$2.44 ( 0% ) Wednesday, 19th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.43 | $3.32 | Wednesday, 19th Jan 2022 CLVS stock ended at $2.44. During the day the stock fluctuated 6.56% from a day low at $2.44 to a day high of $2.60. |
| 90 days | $2.43 | $4.76 | |
| 52 weeks | $2.43 | $11.10 |
Historical Clovis Oncology prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-19 | $2.50 | $2.60 | $2.44 | $2.44 | 4 280 958 |
| 2022-01-18 | $2.65 | $2.66 | $2.43 | $2.44 | 6 216 878 |
| 2022-01-14 | $2.50 | $2.72 | $2.45 | $2.71 | 4 862 758 |
| 2022-01-13 | $2.58 | $2.62 | $2.50 | $2.54 | 3 865 806 |
| 2022-01-12 | $2.75 | $2.82 | $2.58 | $2.58 | 3 165 108 |
| 2022-01-11 | $2.65 | $2.84 | $2.63 | $2.73 | 3 869 756 |
| 2022-01-10 | $2.53 | $2.64 | $2.46 | $2.59 | 3 981 666 |
| 2022-01-07 | $2.75 | $2.82 | $2.55 | $2.55 | 4 802 803 |
| 2022-01-06 | $2.74 | $2.83 | $2.63 | $2.71 | 3 046 100 |
| 2022-01-05 | $2.91 | $3.00 | $2.67 | $2.67 | 4 090 191 |
| 2022-01-04 | $3.12 | $3.13 | $2.90 | $2.91 | 3 344 018 |
| 2022-01-03 | $2.75 | $3.14 | $2.75 | $3.14 | 4 318 088 |
| 2021-12-31 | $2.85 | $2.94 | $2.69 | $2.71 | 3 930 112 |
| 2021-12-30 | $2.74 | $3.00 | $2.71 | $2.85 | 4 614 883 |
| 2021-12-29 | $2.75 | $2.80 | $2.66 | $2.74 | 3 828 103 |
| 2021-12-28 | $2.88 | $3.02 | $2.77 | $2.77 | 3 398 940 |
| 2021-12-27 | $3.16 | $3.16 | $2.86 | $2.86 | 3 864 205 |
| 2021-12-23 | $3.13 | $3.22 | $3.05 | $3.17 | 2 821 135 |
| 2021-12-22 | $3.16 | $3.25 | $3.13 | $3.15 | 1 982 736 |
| 2021-12-21 | $3.23 | $3.32 | $3.13 | $3.18 | 3 382 077 |
| 2021-12-20 | $3.05 | $3.30 | $2.99 | $3.21 | 3 375 390 |
| 2021-12-17 | $2.71 | $3.22 | $2.71 | $3.17 | 6 630 319 |
| 2021-12-16 | $2.88 | $2.92 | $2.72 | $2.75 | 3 612 521 |
| 2021-12-15 | $2.70 | $2.85 | $2.58 | $2.84 | 4 450 639 |
| 2021-12-14 | $2.69 | $2.77 | $2.63 | $2.70 | 3 267 733 |
| 2021-12-13 | $2.80 | $2.89 | $2.62 | $2.70 | 4 227 247 |
| 2021-12-10 | $2.97 | $2.97 | $2.76 | $2.77 | 2 847 465 |
| 2021-12-09 | $3.11 | $3.16 | $2.91 | $2.91 | 3 799 344 |
| 2021-12-08 | $3.10 | $3.19 | $3.00 | $3.16 | 3 144 569 |
| 2021-12-07 | $2.87 | $3.18 | $2.86 | $3.08 | 5 675 855 |
| 2021-12-06 | $2.77 | $2.87 | $2.71 | $2.81 | 4 111 824 |
| 2021-12-03 | $3.11 | $3.11 | $2.75 | $2.76 | 5 394 603 |
| 2021-12-02 | $3.00 | $3.13 | $2.97 | $3.11 | 5 099 194 |
| 2021-12-01 | $3.13 | $3.28 | $2.93 | $2.94 | 5 170 159 |
| 2021-11-30 | $3.05 | $3.18 | $3.02 | $3.16 | 4 358 378 |
| 2021-11-29 | $3.23 | $3.30 | $3.06 | $3.09 | 3 675 434 |
| 2021-11-26 | $3.32 | $3.33 | $3.14 | $3.20 | 2 873 533 |
| 2021-11-24 | $3.24 | $3.41 | $3.15 | $3.34 | 2 738 237 |
| 2021-11-23 | $3.07 | $3.34 | $3.04 | $3.27 | 7 002 696 |
| 2021-11-22 | $3.38 | $3.41 | $3.11 | $3.12 | 5 450 935 |
| 2021-11-19 | $3.46 | $3.47 | $3.34 | $3.38 | 4 237 825 |
| 2021-11-18 | $3.64 | $3.70 | $3.39 | $3.49 | 5 574 356 |
| 2021-11-17 | $3.81 | $3.86 | $3.61 | $3.63 | 4 356 240 |
| 2021-11-16 | $3.89 | $3.91 | $3.78 | $3.84 | 3 286 401 |
| 2021-11-15 | $3.96 | $4.00 | $3.87 | $3.88 | 2 813 361 |
| 2021-11-12 | $3.99 | $4.05 | $3.90 | $3.94 | 3 484 769 |
| 2021-11-11 | $4.11 | $4.13 | $3.95 | $3.99 | 6 535 051 |
| 2021-11-10 | $4.26 | $4.26 | $4.09 | $4.11 | 4 002 966 |
| 2021-11-09 | $4.35 | $4.36 | $4.24 | $4.25 | 2 216 885 |
| 2021-11-08 | $4.47 | $4.51 | $4.33 | $4.36 | 2 167 362 |
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucapar... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
